The most common individual cancer drugs causing DIILD were identified as bleomycin, gemcitabine, epidermal growth factor receptor (EGFR)-directed therapies, mechanistic target of rapamycin protein (MTOR) inhibitors and immune checkpoint inhibitors. This evidence concerns the gene MTOR and cancer.